Reggenerate logo
MARKET & TRENDS

Nutraceuticals: What Mattered in October 2026

04 Nov 2026 • 7 min read

By Chloé Vernet, Sales & Marketing Manager at Circul'Egg

In October, two ingredients that seemed settled changed regulatory status in Europe, in opposite directions. It is the most useful signal of the month for a supplement brand: an active's compliance is proven form by form, and what was taken for granted yesterday can be questioned tomorrow.

What to remember from October 2026: the novel food framework is getting sharper and stricter, GLP-1 users are becoming a support target rather than a weight-loss promise, mobility is shifting toward prevention, indulgent formats are under scrutiny and green claims now have to be substantiated. For each trend, here is the fact, its source, and what we at Circul'Egg take from it for your formulas.

Novel foods: an ingredient's status is checked form by form

The month brought two decisions pointing in opposite directions. On one side, a form of SAMe was reclassified as non-novel in food supplements across all 27 Member States, after a consultation filed in Lithuania (NutraIngredients, October 20, 2026). On the other, a new red yeast rice strain was classified as a novel food in Italy: the consumption history of conventional red yeast rice does not extend to a different strain (NutraIngredients, October 28, 2026).

The same month, a think tank launched a support program to help companies prepare their dossiers, noting that an authorization takes around two and a half years in practice, sometimes much longer (NutraIngredients, October 15, 2026). In the United States, the FDA published its final guidance on NDI notifications, detailing what it expects on ingredient identity and safety (NutraIngredients, October 19, 2026).

What it changes for your brand

A derivative, a new process or a new strain can move an ingredient into a different regulatory category. In practice, we advise our clients to ask every supplier for a written, reasoned position on the status of its ingredient, in the exact form that will be delivered. If you are targeting the US market, add a complete identity dossier: specifications, impurities, process description. And in your launch planning, a truly new ingredient is counted in years, not months.

GLP-1: support users rather than promise satiety

The analyses published in October agree: people on GLP-1 treatment look for products to preserve muscle mass, fill micronutrient gaps and take care of their hair and nails (NutraIngredients, October 16, 2026). In European data cited on October 28, nearly 60% of current users say they take more supplements, with protein and vitamin D in the lead (NutraIngredients, October 28, 2026).

At the same time, EFSA rejected a claim application based on satiety, considering that appetite ratings alone are not enough to demonstrate a beneficial physiological effect (NutraIngredients, October 27, 2026).

What it changes for your brand

Let's be honest: positioning a product as a GLP-1 alternative is a dead end in Europe. The solid ground is everyday support during and after treatment: muscles, bones, joints, skin, hair. These consumers eat less, so every capsule has to count. Actives that fit into a small daily dose are gaining value, especially while dairy protein prices stay high.

Joints: from age-related discomfort to active mobility

Bone and joint ingredient suppliers are repositioning their message toward prevention and long-term mobility, beyond the senior audience alone (Nutrition Insight, October 5, 2026). At SupplySide Global, one supplier organized its longevity offer by life stage, with a mobility focus aimed at perimenopause and menopause (Nutrition Insight, October 30, 2026).

What it changes for your brand

The target is widening: active adults, weekend athletes, women after menopause. These consumers want a product that is simple to take every day, often combined with other benefits (bones, muscle, skin). Our position is clear: for a mainstream mobility formula, the dosage form decides before the marketing does. An active that needs several grams a day locks you into powder. Our comparison of joint supplement ingredients details the doses and formats of each family. On pack, rely on nutrients with authorized claims, such as vitamin C, which contributes to normal collagen formation for the normal function of cartilage.

Beauty from within: healthy aging, and indulgent formats under control

A survey of 3,000 consumers in China, the UK and the US ranks physical strength and mobility at the top of age-related concerns, ahead of skin, and shows that younger consumers link beauty with hormonal balance (NutraIngredients, October 13, 2026). On formats, FDA scientists reminded the industry that gummies should not be treated as simple candy and that overages must not make up for poor manufacturing practices. US gummy sales reached 4.88 billion dollars over 52 weeks according to SPINS (NutraIngredients, October 7, 2026).

What it changes for your brand

The message is moving from anti-aging to healthy aging, with promises that combine skin, hair and mobility. For gummies and stick packs, an active's dose becomes the selection criterion: the less you need, the more room is left for texture and taste, and the easier the assay is to keep on target until the best-before date. Avoid comfort overages: they replace neither stability nor quality control. In Europe, "glow" and "beauty" are not claims: pair biotin, zinc or vitamin C for your on-pack message.

Upcycling: a circular origin now has to be proven

EU Directive 2024/825 on misleading commercial practices has applied since September 27, 2026. It bans generic environmental claims and unrecognized labels, and places the burden of proof on the company making the claim (NutraIngredients, opinion piece, October 28, 2026). Meanwhile, a 12-month trial in 316 postmenopausal women, run with the supplier, studied calcium from a dairy co-product and reports that bone mineral density was maintained compared with placebo (NutraIngredients, October 22, 2026).

What it changes for your brand

The "made from co-products" story is appealing, but it is no longer enough. Every "upcycled" or "circular" statement must rest on a written file: origin of the material, process, supplier documents, exact wording of the claim in each language. For packaging shared across several countries, follow the strictest rule. Frankly, this is good news for serious brands: proof becomes a competitive advantage.

Where eggshell membrane fits in

These five trends draw the same set of requirements: a clear regulatory status, a low dose, compatibility with small formats and a traceable origin. That is the grid we apply to Reggenerate®, native eggshell membrane. It is non-hydrolyzed, obtained through a 100% mechanical, solvent-free process, and used at 300 mg per day. It naturally contains collagen (types I, V and X), elastin, hyaluronic acid, glucosamine and chondroitin. It comes from upcycled eggshells, and Circul'Egg is a Breton company based in Janzé.

Frequently asked questions

How do you know whether an ingredient is a novel food in Europe?

You need to establish significant consumption in the Union before May 15, 1997, for the exact form used. Ask your supplier for a written position and, if in doubt, a consultation with a national authority. October's decisions show that a new strain or a new process can change the answer.

Can a food supplement target GLP-1 users?

Yes, as long as it sticks to authorized claims and everyday support: vitamin and mineral intake, protein, skin or hair support through nutrients with authorized claims. Satiety and weight loss remain tightly regulated areas in Europe.

Can you write "upcycled" on a food supplement?

Yes, if the statement is precise, verifiable and documented. Directive 2024/825 mainly targets vague claims, such as "environmentally friendly", and unrecognized labels. Keep an up-to-date evidence file for each statement and each market.

Chloé Vernet, Sales & Marketing Manager at Circul'Egg